The purpose of this advisory is to call your attention to important guidelines for the safe use of insulin pens. Recently, two facilities in New York State discovered that insulin pens, designed for use on a single patient, had been used or might have been used for multiple patients.
The Centers for Medicare and Medicaid Services (CMS) have notified state survey directors that effective immediately, they have eliminated the 30-minute rule for medication administration.
The anemia drug peginesatide (Omontys, Affymax and Takeda Pharmaceuticals) has been voluntarily recalled by the manufacturers, after reports of anaphylaxis leading to 3 deaths, the US Food and Drug Administration (FDA) announced today.
In November 2012, the United States Pharmacopeial Convention (USP) revised its current standards for labels for heparin sodium injection solutions to help address safety concerns regarding the expression of drug strength.